- Issuer ticker
-
LEXX
- Reported as of
-
15 May 2025
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
16 May 2025, 16:44:04 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/Baljinder Bhullar/
Key filing fact
Baljinder Bhullar filed Form 4 for Lexaria Bioscience Corp. (LEXX) on 16 May 2025.
Key facts
- This page summarizes Baljinder Bhullar's Form 4 filing for Lexaria Bioscience Corp. (LEXX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 16 May 2025, 16:44.
Change
- Previous filing in this sequence was filed on 16 Jan 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001401225
Primary reporting owner
Bhullar Baljinder
- Relationship
-
Director
- Address
- 704 ALEXANDER STREET, VANCOUVER, BRITISH COLUMBIA, CANADA
- Signature
- /Baljinder Bhullar/
- Signature date
- 16 May 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LEXX
holding
common shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 13,000
- Date
- 15 May 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LEXX
transaction
Derivative
Stock Options
Award
- Transaction value
- $0
- Shares
- +11,000
- Change %
- Price
-
$0.000000
- Shares after
- 11,000
- Date
- 15 May 2025
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 11,000
- Exercise price
- $1.04
* marks a reported price that did not pass the local price check.